The emerging therapy of this peptide represents a exciting breakthrough in the care of type 2 diabetes. Unlike existing therapies, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatidepeptide998211.iyublog.com/40797402/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment